Topic: How To Invest

Dear Pat: What is your opinion of Dyadic International? Thanks.

Article Excerpt

Dyadic International, $2.00, symbol DYAI on the U.S. over-the-counter market (Shares outstanding: 31.0 million; Market cap: $62.0 million, www.dyadic-group.com), develops biological products, such as proteins, enzymes, polypeptides and small molecules. These are used in the agricultural, industrial, bioenergy, chemical and biopharmaceutical industries. Dyadic has already licensed its C1 fungus to energy developer Codexis Inc. on a non-exclusive basis. This client aims to use the fungus to make bioethanol and other sugar-based products from biomass (such as grass and other plant material), and from corn and other crops. In the three months ended September 30, 2010, Dyadic’s revenue fell 4.9%, to $2.0 million from $2.1 million a year earlier. The company lost $1.4 million, or $0.04 a share. A year earlier, it lost $654,425, or $0.02 a share. Dyadic’s technology is promising. But to benefit most, it needs greater use of green technologies in the U.S. As well, the company needs to form new research and business partnerships to advance and…